Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…

Astrazeneca Aktie: Enttäuschende Studienergebnisse belasten Kurs

Die Astrazeneca-Aktie gerät unter Druck, nachdem die Deutsche Bank Research ihre Einschätzung von "Halten" auf "Verkaufen" herabgestuft und das Kursziel…

AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls

AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the…

AstraZeneca: Upgrade

Wien (www.aktiencheck.de) - Rating-Update: Hans Engel, Analyst von Erste Group Research, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…

DEUTSCHE BANK RESEARCH stuft ASTRAZENECA auf Sell

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000 auf…

Deutsche Bank Research senkt Astrazeneca auf Sell

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft und das Kursziel von 11000…

AstraZeneca: Herabstufung

Stockholm (www.aktiencheck.de) - Rating-Update: Die Analysten von Nordea stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…

AstraZeneca: Dato-DXd Should Still Be Approved In Q4 Despite Underwhelming Data

…

GOLDMAN SACHS stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 15914 Pence…

Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug By Proactive Investors

Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug…

FTSE 100 dips as AstraZeneca weighs, Centamin takeover lifts precious metals miners

The FTSE 100 dipped on Tuesday as AstraZeneca weighed on the index after announcing disappointing developments for a lung cancer…

AstraZeneca Defends China Compliance In Wake of Staff Detentions

AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees…

AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant…

AstraZeneca shares down on disappointing drug trial results By Investing.com

AstraZeneca shares down on disappointing drug trial results…

FTSE 100 falls as AstraZeneca weighs; slowing wage growth cements rate cut bets By Reuters

FTSE 100 falls as AstraZeneca weighs; slowing wage growth cements rate cut bets…

European shares hold ground as AstraZeneca drags, tech shares rise By Reuters

European shares hold ground as AstraZeneca drags, tech shares rise…

FTSE 100 Live: Londons premier index closes out bearish session

FTSE 100 falls by 70 points AstraZeneca off 3% JD Sports leads footsie risers 4.01pm: FTSE 100 flounders The FTSE 100…

FTSE 100 Live: Blue chips hit intraday lows led by AstraZeneca

FTSE 100 falls by 72 points AstraZeneca off 3% JD Sports leads footsie risers 3.30pm: FTSE 100 hits intraday lows Londons…

FTSE 100 Live: Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug

FTSE 100 falls by 37 points AstraZeneca off nearly 5% UK jobs data mixed 11.59am: iPhone 16 met with relative indifference…

FTSE 100 Live: Blue chips dragged by AstraZeneca, Nasdaq higher despite Apple sell off

FTSE 100 falls by 43 points AstraZeneca off nearly 5% JD Sports leads footsie risers 2.51pm: Nasdaq rallies The Nasdaq 100…

FTSE 100 Live: Blue chips dragged by AstraZeneca, Ocado outstrips rivals

FTSE 100 falls by 35 points AstraZeneca off nearly 5% UK jobs data mixed 11.02am: AstraZeneca the biggest FTSE faller of…

Daiichi Sankyo Plunges on Mixed Trial Result of Lung Cancer Drug

Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer…

AstraZeneca reports disappointing Phase 3 data for lung cancer ADC

…

AstraZeneca Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Auf…

JPMorgan belässt Astrazeneca auf Overweight - Ziel 14000 Pence

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Auf…

AstraZeneca says staff detained in China amid reports of a drug-import investigation

Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the…

AstraZeneca slides after confirming five employees held by China police

AstraZeneca PLC (LSE:AZN) shares fell 3.5% after it confirmed that five current and former employees in China are being held by…

AstraZeneca confirms five employees held by China police

AstraZeneca PLC (LSE:AZN) has confirmed that five current and former employees in China are being held by police for questioning.…

China Detains AstraZeneca Staff in Data, Drug-Import Probes

Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about potential illegal…

Total Voting Rights

2 September 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

Gothenburg and AstraZeneca deepen ties to strengthen life science sector

Gothenburg is to get its first regional business strategy for life science. The initiative comes from Business Region Göteborg and…

QIAGEN and AstraZeneca Expand Pact to Develop CDx in Chronic Diseases

QGENs expanded collaboration with AstraZeneca to focus on developing companion diagnostics beyond oncology.…

Qiagen mit aussichtsreicher Kooperation

Qiagen sammelt einen weiteren Pluspunkt. Der Spezialist im Bereich der molekularen Diagnostik kann die bisherige strategische Partnerschaft mit AstraZeneca ausweiten.…

GNW-Adhoc: Partnerschaft für Begleitdiagnostika für chronische Krankheiten: QIAGEN weitet Anwendung von QIAstat-Dx auf die Präzisionsmedizin aus

^Neue Vereinbarung erweitert die Zusammenarbeit mit AstraZeneca über dieOnkologie hinaus - einschließlich komplexer chronischer Erkrankungen // QIAGENssyndromische Testplattform QIAstat-Dx ermöglicht…

Top Analyst Reports for Linde, AstraZeneca & Walt Disney

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The…

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Per third-party reports, AstraZeneca (AZN) has refuted rumors about considering a change in the relocation of a vaccine manufacturing plant…

AstraZeneca warns of moving UK vaccine production to US, FT reports By Reuters

AstraZeneca warns of moving UK vaccine production to US, FT reports…

Billion-dollar Deals in Radiopharmaceuticals Catch Investor Attention

Recent mergers and acquisitions and partnership deals in the medical industry are showing signs of increasing investor interest in the…

Imfinzi approved in US for resectable lung cancer

16 August 2024 Imfinzi approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery Based on AEGEAN…

FDA Expands AstraZenecas (AZN) Imfinzi Label in Lung Cancer

This approval is based on late-stage study data, which shows that treatment with AstraZenecas (AZN) Imfinzi reduced the risk of…

Pharma Stock Roundup: AZN Gets Approvals for Imfinzi Expanded Use, MRK Inks New Deal

Merck (MRK) signs a new collaboration with a private drugmaker. AstraZeneca (AZN) gets approvals for expanded use of Imfinzi.…

How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise?

AstraZenecas (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several…

GOLDMAN SACHS stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca nach veröffentlichten Fachartikeln für die anstehende…

Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso

…

AstraZeneca’s Market Cap Soars Past £200 Billion for First Time

AstraZeneca Plc has become the first British company to be valued at more than £200 billion ($257 billion) after a…

The state of digital health investment, part 3: AstraZeneca

Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharmas perspective on digital health investments and partnerships for…

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments…

dpa-AFX ProFeed